Acute Ischemic Stroke and Reperfusion Therapy
Research activity includes acute ischemic stroke care, with interest in patients who have residual occlusion after mechanical thrombectomy and in those receiving intravenous thrombolysis despite recent direct oral anticoagulant use. The clinical focus extends to improving neurological recovery and treatment safety in complex stroke presentations.
- Tenecteplase
- Thrombolysis after thrombectomy
- Direct oral anticoagulants
Additional interest lies in optimizing reperfusion strategies when standard treatment pathways are constrained by prior anticoagulant exposure or incomplete vessel reopening.
Pediatric Stroke and Focal Cerebral Arteriopathy
The sponsor is active in childhood stroke research, particularly focal cerebral arteriopathy, an inflammatory vessel wall disease linked to infection. The therapeutic emphasis is on preventing progression of arterial narrowing and reducing the risk of recurrent cerebrovascular events in children.
- Inflammatory arteriopathy
- Childhood ischemic stroke
- Anti-inflammatory treatment
Clinical interest also includes the interaction between vascular inflammation and stroke outcome in the pediatric setting.
Venous Thromboembolism and Pulmonary Embolism
Trial activity covers isolated subsegmental pulmonary embolism, with focus on the balance between clinical surveillance and anticoagulation in low-risk patients. The research addresses recurrence prevention while considering bleeding risk and treatment intensity.
- Subsegmental pulmonary embolism
- Venous thromboembolism
- Anticoagulation strategy
This area reflects interest in refining management for smaller clot burden disease within pulmonary vascular medicine.
Atrial Fibrillation and Coronary Intervention
Research includes patients with atrial fibrillation who have undergone percutaneous coronary intervention and stent implantation. The therapeutic domain centers on antithrombotic treatment choices that address both cardiac and cerebral ischemic risk while limiting bleeding complications.
- Antithrombotic therapy
- Percutaneous coronary intervention
- Stent-related care
Attention is directed toward treatment strategies for patients requiring long-term anticoagulant management after coronary revascularization.
